A heads up on upcoming Facebook policy changes that will impact “commenting” on pharmaceutical and financial services brand pages.
Facebook will be changing their policy when it comes to disabling comments. At some point, possibly as early as mid-June, Facebook will be opening up comments on all pharma Pages with the exceptions of the following:
- Pages that promote, talk about, or support prescription drugs or devices
- Pages that focus on a disease state where there is only one prescribed treatment (even if the Page doesn’t mention the treatment)
- Disease-state/therapeutic area Pages that have the PI/ISI on the Page
Currently, Page administrators have the ability to disable comments to Wall posts, photos, and videos which is vital for pharma and financial services brand pages as they work in highly regulated industries. It would be very difficult to deal with open comments from the Facebook community in these particular verticals.
There will be more information on this in the coming weeks…although only pharma is discussed, we believe financial services will also be impacted by this Facebook Page commenting change.